Clinical impact potential of Rejuveinix (RJX) for prevention of fatal acute respiratory distress syndrome (ARDS) and multi-organ failure in COVID-19 patients.
暂无分享,去创建一个
F. Uckun | K. Şahin | Natalie M. Pizzimenti | T. K. Şahin | Joy Powell | Kristina Cabala | Jackie Earabino | Peter Pacult | J. Ervin | H. V. Wyk | Mariette van Wyk